Advertisement
FDA revised product labeling for all NSAIDs, including COX-2 inhibitors in 2005 to warn about cardiovascular effects, including heart attacks, and gastrointestinal side effects, such as stomach bleeding. FDA determined that these effects were related to the entire class of drugs, and advised the use of the lowest possible dose for the shortest duration.
Continue Learning about Nonsteroidal Anti-inflammatory Drugs
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.